Toral R Patel Selected Research

Glioma (Gliomas)

9/2023	MRI-Based Deep Learning Method for Classification of IDH Mutation Status.
1/2022	Neutrophilia and post-radiation thrombocytopenia predict for poor prognosis in radiation-treated glioma patients.
1/2020	Glycine by MR spectroscopy is an imaging biomarker of glioma aggressiveness.
1/2020	A novel fully automated MRI-based deep-learning method for classification of IDH mutation status in brain gliomas.
1/2020	In vivo MRS measurement of 2-hydroxyglutarate in patient-derived IDH-mutant xenograft mouse models versus glioma patients.
1/2020	A novel fully automated MRI-based deep-learning method for classification of 1p/19q co-deletion status in brain gliomas.
1/2019	3D high-resolution imaging of 2-hydroxyglutarate in glioma patients using DRAG-EPSI at 3T in vivo.
1/2018	Echo-planar spectroscopic imaging with dual-readout alternated gradients (DRAG-EPSI) at 7 T: Application for 2-hydroxyglutarate imaging in glioma patients.
11/2016	Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toral R Patel Research Topics

Disease

13	Neoplasms (Cancer) 01/2023 - 01/2012
9	Glioma (Gliomas) 09/2023 - 11/2016
6	Brain Neoplasms (Brain Tumor) 01/2023 - 08/2012
4	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 07/2013
2	Neoplasm Metastasis (Metastasis) 09/2019 - 01/2019
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Ischemia 05/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 05/2021
1	Death (Near-Death Experience) 05/2020
1	Lymphadenopathy 03/2020
1	Ependymoma 03/2020
1	Fever (Fevers) 09/2019
1	Melanoma (Melanoma, Malignant) 09/2019
1	Neurologic Manifestations (Neurological Manifestations) 09/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2019
1	Brain Abscess (Abscess, Brain) 09/2019
1	Heart Failure 01/2019
1	Hemangiopericytoma 01/2019
1	Solitary Fibrous Tumors 01/2019
1	Nervous System Diseases (Neurological Disorders) 09/2017
1	Astrocytoma (Pilocytic Astrocytoma) 11/2016
1	Oligodendroglioma 11/2016
1	Seizures (Absence Seizure) 01/2012
1	Stroke (Strokes) 01/2009
1	Pathologic Constriction (Stenosis) 01/2009

Drug/Important Bio-Agent (IBA)

7	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 09/2023 - 11/2016
6	alpha-hydroxyglutarateIBA 10/2021 - 11/2016
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2020 - 09/2017
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2016
2	Temozolomide (Temodar)FDA LinkGeneric 12/2019 - 11/2016
1	TESIBA 01/2022
1	LipidsIBA 10/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	Pyruvic Acid (Pyruvate)IBA 01/2021
1	Glycine Hydroxymethyltransferase (Serine Hydroxymethyltransferase)IBA 01/2020
1	Amino Acids FDA Link 01/2020
1	CarbonIBA 01/2020
1	EnzymesIBA 01/2020
1	GadoliniumIBA 01/2020
1	NucleotidesIBA 01/2020
1	Glycine Dehydrogenase (Decarboxylating)IBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2019
1	Immune Checkpoint InhibitorsIBA 09/2019
1	NivolumabIBA 09/2019
1	IpilimumabIBA 09/2019
1	Protons (Proton)IBA 11/2016
1	Carmustine (FIVB)FDA Link 11/2016
1	Small Interfering RNA (siRNA)IBA 01/2012
1	PolymersIBA 01/2012
1	Peptides (Polypeptides)IBA 01/2012
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2009

Therapy/Procedure

10	Therapeutics 01/2023 - 01/2009
6	Radiotherapy 01/2023 - 08/2012
4	Drug Therapy (Chemotherapy) 01/2021 - 07/2013
3	Aftercare (After-Treatment) 01/2023 - 01/2012
1	Neck Dissection (Radical Neck Dissection) 03/2020
1	Craniotomy 09/2019
1	Transcatheter Aortic Valve Replacement 01/2019
1	Adjuvant Radiotherapy 01/2019
1	Operative Surgical Procedures 11/2016